Skip to main content
logo
Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.7843
+0.0365 (4.88%)
At close: Sep 18, 2026, 4:00 PM EDT
0.7706
-0.0137 (-1.75%)
After-hours: Sep 18, 2026, 7:30 PM EDT

Daré Bioscience Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
0.190.151.020-0.020.03-0.060.040.020.011.811----10---
Revenue Growth (YoY)
-499.58%--94.57%-173.35%--95.83%------------
Cost of Revenue
0.560.9-4.611.181.432.3-10.982.68-3.3621.560.030.030.0330.070.030.030.030.030.03
Gross Profit
-0.37-0.755.63-1.17-1.45-2.2710.91-2.640.02-3.35-19.760.98-0.03-0.03-30.07-0.039.98-0.03-0.03-0.03
Selling, General & Admin
2.592.251.582.52.382.3122.042.452.672.952.72.923.343.232.652.792.572.42.21
Research & Development
--5.52---14.31-4.93--17.746.676.045.02-17.074.466.85.817.1210.43
Operating Expenses
2.592.257.12.52.382.3116.32.047.382.67-14.789.378.968.36-13.847.119.598.389.5212.64
Operating Income
-2.97-3-1.47-3.67-3.83-4.58-5.39-4.68-7.36-6.02-4.97-8.4-8.99-8.38-16.23-7.140.38-8.4-9.54-12.67
Other Non Operating Income (Expenses)
-0.01-00.030.11-0.190.2-0.12-0.0220.27-0.730.110.10.230.340.290.120.03000
EBT Excluding Unusual Items
-2.98-3-1.44-3.56-4.02-4.38-5.51-4.712.91-6.76-4.86-8.3-8.76-8.04-15.94-7.020.41-8.4-9.54-12.67
Other Unusual Items
-----------0.4---------
Pretax Income
-2.98-3-1.44-3.56-4.02-4.38-5.51-4.712.91-6.76-5.06-8.3-8.76-8.04-15.94-7.020.41-8.4-9.54-12.67
Net Income
-2.98-3-1.44-3.56-4.02-4.38-5.51-4.712.91-6.76-5.06-8.3-8.76-8.04-15.94-7.020.41-8.4-9.54-12.67
Net Income to Common
-2.98-3-1.44-3.56-4.02-4.38-5.51-4.712.91-6.76-5.06-8.3-8.76-8.04-15.94-7.020.41-8.4-9.54-12.67
Net Income Growth (YoY)
--------------------
Shares Outstanding (Basic)
151514139989887877777746
Shares Outstanding (Diluted)
151514139989887877777746
Shares Change (YoY)
67.84%65.80%78.14%49.45%4.66%4.57%9.92%12.48%17.72%17.54%7.26%7.34%1.21%1.87%56.89%19.85%69.26%88.63%36.12%124.06%
EPS (Basic)
-0.20-0.21-0.10-0.28-0.45-0.50-0.69-0.551.53-0.81-0.69-1.09-1.22-1.13-2.34-0.990.06-1.20-2.20-2.15
EPS (Diluted)
-0.20-0.21-0.10-0.28-0.45-0.50-0.69-0.551.52-0.81-0.70-1.09-1.22-1.13-2.34-0.990.06-1.20-2.20-2.15
EPS Growth (YoY)
--------------------

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
-6.86-5.521.24-0.62-5.26-5.634.74-5.6412.62-6.82-8.79-8-6.59-16.12-5.98.55-8.45-12.35-9.921.31
Free Cash Flow Per Share
-0.46-0.380.09-0.05-0.59-0.640.59-0.661.49-0.81-1.20-1.05-0.92-2.26-0.871.21-1.19-1.76-2.290.22
Gross Margin
-199.58%-549.90%-----100.00%--97.50%----99.75%---
Operating Margin
-1582.53%-1967.07%-143.72%-162340.76%--18016.75%--11228.68%-32799.12%-64743.85%-274.99%-839.64%----3.84%---
Profit Margin
-1590.42%-1967.72%-140.84%-157505.13%--17219.13%--11279.42%57539.25%-72622.62%-279.75%-829.91%----4.14%---
Free Cash Flow Margin
-3655.44%-3621.16%120.90%-27269.54%--22133.46%--13532.32%56241.46%-73320.34%-486.00%-799.59%-----84.49%---
EBITDA
-2.4-2.44-0.94-3.19-3.37-4.41-5.38-4.67-7.34-6.01-4.96-8.39-8.98-8.37-16.22-7.140.39-8.4-9.54-12.66
EBITDA Margin
---91.52%--------274.44%-----3.90%---
D&A For EBITDA
0.570.550.530.480.450.180.010.010.020.010.010.010.010.010.0100.010.010.010.01
EBIT
-2.97-3-1.47-3.67-3.83-4.58-5.39-4.68-7.36-6.02-4.97-8.4-8.99-8.38-16.23-7.140.38-8.4-9.54-12.67
EBIT Margin
---143.72%--------274.99%-----3.84%---
Revenue as Reported
0.190.151.020-0.020.03-0.040.020.011.811----10---
SEC Filings: 10-K · 10-Q